https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2018-0876.html
Immuno-Chemotherapy as single treatment modality for Larynx Preservation (ICoLP)
This phase II trial studies how well cisplatin, docetaxel, and pembrolizumab work in treating patients with stage II-III laryngeal cancer. Drugs used in...
immunochemotherapysingletreatmentmodality